GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,144,000 | +114.6% | 16,806 | +0.7% | 0.01% | +140.0% |
| Q2 2022 | $533,000 | -1.8% | 16,688 | +6.4% | 0.01% | +25.0% |
| Q1 2022 | $543,000 | +22.6% | 15,678 | +3.7% | 0.00% | +33.3% |
| Q4 2021 | $443,000 | +13.9% | 15,118 | -1.0% | 0.00% | 0.0% |
| Q3 2021 | $389,000 | -27.0% | 15,265 | +0.4% | 0.00% | -25.0% |
| Q2 2021 | $533,000 | -19.2% | 15,206 | -6.1% | 0.00% | -33.3% |
| Q1 2021 | $660,000 | -4.9% | 16,190 | +1.1% | 0.01% | 0.0% |
| Q4 2020 | $694,000 | -24.0% | 16,016 | -3.2% | 0.01% | -33.3% |
| Q3 2020 | $913,000 | +17.1% | 16,549 | +33.9% | 0.01% | -18.2% |
| Q2 2020 | $780,000 | +8.0% | 12,357 | -12.6% | 0.01% | -8.3% |
| Q1 2020 | $722,000 | – | 14,140 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |